Thorough QT/QTc (TQT) Clinical Study to Evaluate the Effects of Ziresovir on Cardiac Repolarization in Healthy Subjects
Clinical trial NCT06591845 · COMPLETED
Trial details
- NCT number
- NCT06591845
- Sponsor
- Shanghai Ark Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2024-12-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.